| Primary |
| Product Used For Unknown Indication |
46.4% |
| Hypertension |
19.6% |
| Essential Hypertension |
5.2% |
| Atrial Fibrillation |
3.1% |
| Hypercholesterolaemia |
3.1% |
| Lung Disorder |
3.1% |
| Anaesthesia |
2.1% |
| Angina Pectoris |
2.1% |
| Asthma |
2.1% |
| Lymphadenitis |
2.1% |
| Polycythaemia |
2.1% |
| Arrhythmia |
1.0% |
| Depression |
1.0% |
| Drug Use For Unknown Indication |
1.0% |
| Dyslipidaemia |
1.0% |
| Fungal Infection |
1.0% |
| General Symptom |
1.0% |
| Hormone Therapy |
1.0% |
| Mycosis |
1.0% |
| Sleep Disorder |
1.0% |
|
| Renal Failure Acute |
13.8% |
| Vomiting |
10.3% |
| Myalgia |
6.9% |
| Syncope |
6.9% |
| Thrombocytopenia |
6.9% |
| Toxic Skin Eruption |
6.9% |
| Death |
3.4% |
| Hepatitis |
3.4% |
| Hypertension |
3.4% |
| Hypotension |
3.4% |
| Ischaemic Hepatitis |
3.4% |
| Jaundice |
3.4% |
| Lymphadenopathy |
3.4% |
| Malaise |
3.4% |
| Memory Impairment |
3.4% |
| Prepyloric Stenosis |
3.4% |
| Procedural Complication |
3.4% |
| Pruritus |
3.4% |
| Rash Maculo-papular |
3.4% |
| Renal Failure |
3.4% |
|
| Secondary |
| Product Used For Unknown Indication |
29.6% |
| Hypertension |
24.6% |
| Drug Use For Unknown Indication |
10.6% |
| Hiv Infection |
5.6% |
| Age-related Macular Degeneration |
5.0% |
| Hypercholesterolaemia |
3.4% |
| Pulmonary Arterial Hypertension |
2.8% |
| Asthma |
2.2% |
| Atrial Fibrillation |
1.7% |
| Bronchospasm |
1.7% |
| Hypertension Arterial |
1.7% |
| Ill-defined Disorder |
1.7% |
| Liver Disorder |
1.7% |
| Alcoholism |
1.1% |
| Atrial Tachycardia |
1.1% |
| Duodenitis |
1.1% |
| Essential Hypertension |
1.1% |
| Gastric Ulcer |
1.1% |
| Muscle Spasms |
1.1% |
| Polycythaemia |
1.1% |
|
| Hypertrophic Cardiomyopathy |
12.8% |
| Renal Failure |
12.8% |
| Renal Failure Acute |
12.8% |
| Pruritus |
10.3% |
| Multi-organ Failure |
5.1% |
| Sinoatrial Block |
5.1% |
| Traumatic Fracture |
5.1% |
| Vascular Purpura |
5.1% |
| Bradycardia |
2.6% |
| Cholestasis |
2.6% |
| Dermatitis Exfoliative |
2.6% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
2.6% |
| Hyperthermia |
2.6% |
| Jaundice Cholestatic |
2.6% |
| Loss Of Consciousness |
2.6% |
| Malaise |
2.6% |
| Microcytic Anaemia |
2.6% |
| Optic Neuritis |
2.6% |
| Persecutory Delusion |
2.6% |
| Positron Emission Tomogram Abnormal |
2.6% |
|
| Concomitant |
| Drug Use For Unknown Indication |
34.4% |
| Hypertension |
15.4% |
| Product Used For Unknown Indication |
8.1% |
| Atrial Fibrillation |
4.0% |
| Type 2 Diabetes Mellitus |
4.0% |
| Hypercholesterolaemia |
3.7% |
| Bronchial Carcinoma |
3.3% |
| Cough |
2.9% |
| Pyrexia |
2.9% |
| Rheumatoid Arthritis |
2.9% |
| Arrhythmia |
2.6% |
| Anxiety |
2.2% |
| Diabetes Mellitus |
2.2% |
| Essential Hypertension |
2.2% |
| Macular Degeneration |
1.8% |
| Anaemia |
1.5% |
| Cardiac Disorder |
1.5% |
| Metastases To Bone |
1.5% |
| Osteoporosis |
1.5% |
| Pain |
1.5% |
|
| Renal Failure Acute |
22.4% |
| Vomiting |
11.9% |
| Rhabdomyolysis |
9.0% |
| Septic Shock |
6.0% |
| Peripheral Artery Thrombosis |
4.5% |
| Thrombocytopenia |
4.5% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
3.0% |
| Hypoglycaemic Coma |
3.0% |
| Intestinal Ischaemia |
3.0% |
| Ischaemic Stroke |
3.0% |
| Malaise |
3.0% |
| Metabolic Acidosis |
3.0% |
| Mydriasis |
3.0% |
| Paraesthesia |
3.0% |
| Phlebitis |
3.0% |
| Rash Maculo-papular |
3.0% |
| Rash Papular |
3.0% |
| Respiratory Disorder |
3.0% |
| Tachyarrhythmia |
3.0% |
| Tendonitis |
3.0% |
|
| Interacting |
| Hypertension |
37.5% |
| Anxiety |
12.5% |
| Arrhythmia |
12.5% |
| Mental Impairment |
12.5% |
| Prophylaxis |
12.5% |
| Prostatic Adenoma |
12.5% |
|
| Drug Interaction |
50.0% |
| Loss Of Consciousness |
50.0% |
|
